Quantitative knowledge-based analysis in compound safety assessment

Bibliography

• Kuhnel MP, Cosovic, B, Medic G, Pathway analysis for drug discovery: computational infrastructure and applications. New York: John Wiley and Sons, Inc.; 2008
   Google Scholar
• The FDA's drug review process: ensuring drugs are safe and effective. Available from: http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143534.htm [Accessed 8 November 2010]
   Google Scholar
• Evens RP. Drug and biological development. Springer; 2007
   Google Scholar
• Valerio LG, Jr. In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol 2009;7:356-70
   Google Scholar
• Muster W, Breidenbach A, Fischer H, Computational toxicology in drug development. Drug Discov Today 2008;13:303-10
   PubMed Web of Science ®Google Scholar
• Nigsch F, Macaluso NJ, Mitchell JB, Computational toxicology: an overview of the sources of data and of modelling methods. Expert Opin Drug Metab Toxicol 2009;5:1-14
   PubMed Web of Science ®Google Scholar
• Ryan TP, Stevens JL, Thomas CE. Strategic applications of toxicogenomics in early drug discovery. Curr Opin Pharmacol 2008;8:654-60
   PubMed Web of Science ®Google Scholar
• Ferrer-Dufol A, Menao-Guillen S. Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences. Toxicol Lett 2009;186:2-8
   PubMed Web of Science ®Google Scholar
• Ellinger-Ziegelbauer H, Aubrecht J, Kleinjans JC, Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol Lett 2009;186:36-44
   PubMed Web of Science ®Google Scholar
• FDA's MicroArray Quality Control (MAQC). Available from: http://www.fda.gov/ScienceResearch/BioinformaticsTools/MicroarrayQualityControlProject/default.htm#MAQC-I, [Accessed 8 November 2010]
   Google Scholar
• Goodsaid FM, Amur S, Aubrecht J, Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact. Nat Rev Drug Discov 2010;9:435-45
   PubMed Web of Science ®Google Scholar
• Frueh FW. Impact of microarray data quality on genomic data submissions to the FDA. Nat Biotechnol 2006;24:1105-7
   PubMed Web of Science ®Google Scholar
• Ganter B, Zidek N, Hewitt PR, Pathway analysis tools and toxicogenomics reference databases for risk assessment. Pharmacogenomics 2008;9:35-54
   PubMed Web of Science ®Google Scholar
• Harrill AH, Rusyn I. Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opin Drug Metab Toxicol 2008;4:1379-89
   PubMed Web of Science ®Google Scholar
• Nikolsky Y, Kirillov E, Zuev R, Functional analysis of OMICs data and small molecule compounds in an integrated “knowledge-based” platform. Methods Mol Biol 2009;563:177-96
   PubMedGoogle Scholar
• Bugrim A, Nikolskaya T, Nikolsky Y. Early prediction of drug metabolism and toxicity: systems biology approach and modeling. Drug Discov Today 2004;9:127-35
   PubMed Web of Science ®Google Scholar
• Ekins S, Nikolsky Y, Nikolskaya T. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends Pharmacol Sci 2005;26:202-9
   PubMed Web of Science ®Google Scholar
• Natsoulis G, El Ghaoui L, Lanckriet GR, Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res 2005;15:724-36
   PubMed Web of Science ®Google Scholar
• Huang Y, Penchala S, Pham AN, Genetic variations and gene expression of transporters in drug disposition and response. Expert Opin Drug Metab Toxicol 2008;4:237-54
   PubMed Web of Science ®Google Scholar
• Bonnefoi H, Potti A, Delorenzi M, Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00 – 01 clinical trial. Lancet Oncol 2007;8:1071-8
   PubMed Web of Science ®Google Scholar
• Eun JW, Ryu SY, Noh JH, Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis. Toxicology 2008;249:176-83
   PubMed Web of Science ®Google Scholar
• Blomme EA, Yang Y, Waring JF. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett 2009;186:22-31
   PubMed Web of Science ®Google Scholar
• Motsinger-Reif AA, Jorgenson E, Relling MV, Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics 2010. [Epub ahead of print]
   Google Scholar
• Shi W, Bessarabova M, Dosymbekov D, Functional analysis of multiple genomic signatures demonstrates that classification algorithms choose phenotype-related genes. Pharmacogenomics J 2010;10:310-23
   PubMed Web of Science ®Google Scholar
• Scheiber J, Chen B, Milik M, Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis. J Chem Inf Model 2009;49:308-17
   PubMed Web of Science ®Google Scholar
• Mendrick DL. Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity. Methods Mol Biol 2008;460:1-22
   PubMedGoogle Scholar
• Kanehisa M, Goto S, Furumichi M, KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010;38(Database issue):D355-60
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-9
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545-50
   PubMed Web of Science ®Google Scholar
• Klebanov L, Glazko G, Salzman P, A multivariate extension of the gene set enrichment analysis. J Bioinform Comput Biol 2007;5:1139-53
   PubMedGoogle Scholar
• Jobson JD. Applied multivariate data analysis. 1st edition. 1991
   Google Scholar
• Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005;365:488-92
   PubMed Web of Science ®Google Scholar
• Ein-Dor L, Kela I, Getz G, Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005;21:171-8
   PubMed Web of Science ®Google Scholar
• Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 2006;103:5923-8
   PubMed Web of Science ®Google Scholar
• Buyse M, Sargent DJ, Grothey A, Biomarkers and surrogate end points-the challenge of statistical validation. Nat Rev Clin Oncol 2010;7:309-17
   PubMed Web of Science ®Google Scholar
• Shi L, Campbell G, Jones WD, The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 2010;28:827-38
   PubMed Web of Science ®Google Scholar
• Nikolsky Y, Ekins S, Nikolskaya T, A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158:20-9
   PubMed Web of Science ®Google Scholar
• Wirapati P, Sotiriou C, Kunkel S, Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008;10:R65
   PubMed Web of Science ®Google Scholar
• Hartwell LH, Hopfield JJ, Leibler S, From molecular to modular cell biology. Nature 1999;402:C47-52
   PubMed Web of Science ®Google Scholar
• Goh KI, Cusick ME, Valle D, The human disease network. Proc Natl Acad Sci USA 2007;104:8685-90
   PubMed Web of Science ®Google Scholar
• Lee E, Chuang HY, Kim JW, Inferring pathway activity toward precise disease classification. PLoS Comput Biol 2008;4:e1000217
   PubMedGoogle Scholar
• Fischer HP. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol Annu Rev 2005;11:1-68
   PubMedGoogle Scholar
• Kiechle FL, Zhang X, Holland-Staley CA. The -omics era and its impact. Arch Pathol Lab Med 2004;128:1337-45
   PubMed Web of Science ®Google Scholar
• Bureeva S, Zvereva S, Romanov V, Manual annotation of protein interactions. Methods Mol Biol 2009;563:75-95
   PubMedGoogle Scholar
• Selkov E Jr, Grechkin Y, Mikhailova N, MPW: the metabolic pathway database. Nucleic Acids Res 1998;26:43-5
   PubMed Web of Science ®Google Scholar
• Available from: http://www.biocarta.com/ [Accessed 8 November 2010]
   Google Scholar
• Available from: http://www.genego.com/metacore.php [Accessed 8 November 2010]
   Google Scholar
• Dezso Z, Nikolsky Y, Nikolskaya T, Identifying disease-specific genes based on their topological significance in protein networks. BMC Syst Biol 2009;23:36
   Google Scholar
• Vellaichamy A, Dezso Z, JeBailey L, “Topological significance” analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response. PLoS One 2010;5:e10936
   Google Scholar
• Shi W, Bugrim A, Nikolsky Y, Characteristics of genomic signatures derived using univariate methods and mechanistically anchored functional descriptors for predicting drug- and xenobiotic-induced nephrotoxicity. Toxicol Mech Methods 2008;18:267-76
   PubMed Web of Science ®Google Scholar
• Hong F., Breitling R., McEntee C.W. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 2006;22:2825-27
   PubMed Web of Science ®Google Scholar
• Huang J, Shi W, Zhang J, Genomic indicators in the blood predict drug-induced liver injury. Pharmacogenomics J 2010;10:267-77
   PubMed Web of Science ®Google Scholar
• Fan X, Lobenhofer EK, Chen M, Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J 2010;10:247-57
   PubMed Web of Science ®Google Scholar
• Xu EY, Perlina A, Vu H, Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem Res Toxicol 2008;21:1548-61
   PubMed Web of Science ®Google Scholar
• Ochs MF. Knowledge-based data analysis comes of age. Brief Bioinform 2009;2:30-9
   Google Scholar
• Baranzini SE, Galwey NW, Wang J, Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009;18:2078-90
   PubMed Web of Science ®Google Scholar
• Stadler ZK, Thom P, Robson ME, Genome-wide association studies of cancer. J Clin Oncol 2010;28:4255-67
   PubMed Web of Science ®Google Scholar
• Seshadri S, Fitzpatrick AL, Ikram MA, Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010;303:1832-40
   PubMed Web of Science ®Google Scholar
• Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 2009;10:392-404
   PubMed Web of Science ®Google Scholar
• Link E, Parish S, Armitage J, SLCO1B1 variants and statin-induced myopathy-a genomewide study. N Engl J Med 2008;359:789-99
   PubMed Web of Science ®Google Scholar
• Zhang K, Cui S, Chang S, i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res 2010;38 Suppl:W90-5
   Google Scholar
• Menashe I, Maeder D, Garcia-Closas M, Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res 2010;70:4453-9
   PubMed Web of Science ®Google Scholar
• Luo L, Peng G, Zhu Y, Genome-wide gene and pathway analysis. Eur J Hum Genet 2010;18:1045-53
   PubMed Web of Science ®Google Scholar
• Zhong H, Yang X, Kaplan LM, Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 2010;86:581-91
   PubMed Web of Science ®Google Scholar
• Hartford C, Yang W, Cheng C, Genome scan implicates adhesion biological pathways in secondary leukemia. Leukemia 2007;21:2128-36
   PubMed Web of Science ®Google Scholar
• Nikolsky Y, Sviridov E, Yao J, Genome-wide functional synergy between amplified and mutated genes in human breast cancer. Cancer Res 2008;68:9532-40
   PubMed Web of Science ®Google Scholar
• Bessarabova M, Poustovalova O, Shi W, Biological pathways and key modulators affected by genetic alterations in four common human cancers. Cancer Res 2011; In press
   Google Scholar
• Campillos M, Kuhn M, Gavin AC, Drug target identification using side-effect similarity. Science 2008;321:263-6
   PubMed Web of Science ®Google Scholar
• Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 2004;32(Database issue):D267-70
   Google Scholar
• Gerstein M, Sonnhammer EL, Chothia C. Volume changes in protein evolution. J Mol Biol 1994;236:1067-78
   Google Scholar
• Gunther S, Kuhn M, Dunkel M, SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 2008;36(Database issue):D919-22
   PubMed Web of Science ®Google Scholar
• Wishart DS, Knox C, Guo AC, DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006;34(Database issue):D668-72
   PubMed Web of Science ®Google Scholar
• Roth BL, Lopez E, Patel S, The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrasment of riches? Neuroscientist 2000;6:252-62
   Web of Science ®Google Scholar
• Nigsch F, Mitchell JBO. Toxicological relationships between proteins obtained from protein target predictions of large toxicity databases. Toxicol Appl Pharmacol 2008;231:225-34
   PubMed Web of Science ®Google Scholar
• Symyx Technologies. MDL Drug Data Report. Available from: http://www.symyx.com [Accessed 8 November 2010]
   Google Scholar
• Oprea TI, Tropsha A, Faulon JL, Systems chemical biology. Nat Chem Biol 2007;3:447-50
   PubMed Web of Science ®Google Scholar
• Elsevier. PharmaPendium. Available from: http://www.pharmapendium.com [Accessed 8 November 2010]
   Google Scholar
• GVK-BIO. GVK Bio database suite. Available from: http://www.gvkbio.com [Accessed 8 November 2010]
   Google Scholar
• Sunset Molecular Discovery LLC. WOMBAT: World of Molecular BioactiVity. [2007.2]. Available from: http://www.sunsetmolecular.com [Accessed 8 November 2010]
   Google Scholar
• Ekins S, Bugrim A, Brovold L, Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica 2006;36:877-901
   PubMed Web of Science ®Google Scholar